As Poslovni Dnevnik writes, the net profit of the Croatian company Podravka in the first half of this year reached an impressive 197.6 million kuna, which is 22.3 percent more than in the same period last year, the company announced on Thursday.
At today’s meeting, the Supervisory Board of Podravka confirmed the unaudited results of the Podravka Group’s operations for the first half of the year, expressing “satisfaction and support for all efforts made to continue the company’s continued profitability growth in these still difficult business conditions caused by the coronavirus pandemic,” in a statement.
In the first half of the year, the Nutrition segment generated a net profit of 136.3 million kuna, which is 13.9 percent more than the year before, while the Pharmaceuticals segment generated a net profit of 61.3 million kuna, or 46.3 percent more, which doesn’t come as a shock considering the global public health crisis we’re still embedded in.
The Croatian company Podravka’s sales revenue in the first half of the year amounted to 2.2 billion kuna and was one percent lower when compared to the comparable period of 2020.
The expected decline in sales revenue compared to 2020 is actually the result of unusually large orders and the creation of additional stocks with customers in March last year caused by the introduction of lockdown in most countries where the Podravka Group operates, the statement said.
It is also stated that when, for example, the total sales revenues from the first half of this year are compared with the comparable period of pre-pandemic 2019, then revenues are actually 4 percent higher, which shows positive trends for the company’s business operations.
Within the Nutrition segment, the largest increase in sales revenue in the first half of the year was achieved in the Culinary business programme in the amount of 2.5 percent.
The Croatian company Podravka points out that the business programme(s) Baby Food, Sweets and Snacks also recorded an increase in sales revenue in the amount of 1.7 percent, while the growth in sales revenue was also recorded in the Podravka food segment, in the amount of 2.4 percent.
In the Pharmaceuticals segment, the largest growth was recorded in the Prescription Drugs category, whose sales revenues increased by 4.3 percent when compared to the first half of 2020.
When observing sales revenues by region, within the Food segment from Podravka, point out the growth of sales revenues in the markets of Western Europe and overseas in the amount of 8.2 percent when compared to the comparable period last year.
In these markets, sales growth was achieved in almost all business programmes, of which the largest absolute growth was generated by the business programmes Culinary, Baby food, sweets and snacks and Podravka food.
The Pharmaceuticals segment achieved the largest relative growth in sales revenue of 13.9 percent within the Central Europe region, due to higher sales in the Prescription Drugs category, the statement said.
For more, follow our business section.
